You are here

Article info

Article menu
Download PDFPDF
Clinical science
Influence of drug therapy on the risk of recurrence of ocular toxoplasmosis

Authors

  • Michael Reich Department of Ophthalmology, University of Heidelberg, Heidelberg, Germany Interdisciplinary Uveitis Center, University of Heidelberg, Heidelberg, Germany PubMed articlesGoogle scholar articles
  • Matthias D Becker Department of Ophthalmology, University of Heidelberg, Heidelberg, Germany Interdisciplinary Uveitis Center, University of Heidelberg, Heidelberg, Germany Department of Ophthalmology, Triemli Hospital, Zürich, Switzerland PubMed articlesGoogle scholar articles
  • Friederike Mackensen Department of Ophthalmology, University of Heidelberg, Heidelberg, Germany Interdisciplinary Uveitis Center, University of Heidelberg, Heidelberg, Germany PubMed articlesGoogle scholar articles
  1. Correspondence to Michael Reich, Interdisciplinary Uveitis Center, University of Heidelberg, Im Neuenheimer Feld 400, Heidelberg D-69120, Germany; m.reich.heidelberg{at}web.de
View Full Text

Citation

Reich M, Becker MD, Mackensen F
Influence of drug therapy on the risk of recurrence of ocular toxoplasmosis
British Journal of Ophthalmology 2016;100:195-199.

Publication history

  • Received January 19, 2015
  • Revised May 16, 2015
  • Accepted June 20, 2015
  • First published July 10, 2015.
Online issue publication 
March 22, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/